The effect of chemo- and chemoimmunotherapy on the presence of circulating melanoma cells in peripheral blood. Preliminary results

Acta Biochimica Polonica

Volumn 45, Issue 1, 1998, Pages 95-102

  Szenajch, Jolanta ^a   Kozak, Agnieszka ^a   Kruszewski, Adam A ^a   Babiej, Ewa ^a   Chomicka, Małgorzata ^a   Struzyna, Jerzy ^a   Wiktor Jȩdrzejczak, Wiesław ^a  

^a CENTRAL CLINICAL HOSPITAL   (Poland)

Author keywords

Chemoimmunotherapy; Chemotherapy; Malignant melanoma; Reverse transcription polymerase chain reaction; Tyrosinase

Indexed keywords

ANTINEOPLASTIC AGENT; MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CELL CULTURE; FEMALE; GENETICS; HUMAN; IMMUNOTHERAPY; MALE; MELANOMA; METHODOLOGY; MIDDLE AGED; MONITORING; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MELANOMA; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MONOPHENOL MONOOXYGENASE; PALLIATIVE CARE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0031610622     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.1998_4323     Document Type: Article

References (18)

1. Barnhill, R.L., Fandrey, K., Levy, M.A., Mihm, M.C., Jr. & Hyman, B. (1992) Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab. Invest. 67, 331-337.
2. Brossart, P., Keilholz, U., Scheibenbogen, C., Möhler, T., Willhauck, M. & Hunstein, W. (1994) Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy. J. Immunol. 15, 38-41.
3. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
4. Cocconi, G., Bella, M., Calabresi, F., Tonato, M., Canaletti, R., Boni, C., Buzzi, F., Ceci, G., Corgina, E., Costa, P., Lottici, R., Papadia, F., Sofra, M.C. & Baccchi, M. (1992) Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N. Engl. J. Med. 327, 516-523.
5. Del Prete, S.A., Maurer, L.H., O'Donnel, J., Forcier, R.J. & Lemarbre, P. (1984) Combination chemotherapy with cisplatin, carmustine, dacarbazine and tamoxifen in malignant melanoma. Cancer Treat. Rep. 68, 1403-1405.
6. Fidler, I.J. (1990) Critical factors in the biology of human cancer metastasis: Twenty-Eigth G.H.A. Clowes Memorial Award Lecture. Cancer Res. 50, 6130-6138.
7. Harning, R., Mainolfi, E., Bystryn, J.C., Henn, M., Merluzzi, V.J. & Rothlein, R. (1991) Serum levels of circulating adhesion molecule 1 in human malignant melanoma. Cancer Res. 51, 5003-5005.
8. Hoon, D.S.B., Wang, Y., Dale, P.S., Conrad, A.J., Schmid, P., Garrison, D., Kuo, Ch., Fashang, L.J., Nizze, A.J. & Morton, D.L. (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J. Clin. Oncol. 13, 2109-2116.
9. Khayat, D., Borel, C. & Tourani, J.M., Benhammouda, A., Antoine, E., Rixe, O., Vuillemin, E., Bazex, P.A., Thill, L. & Franks, R. (1993) Sequential chemoimmunotherapy with cisplatin, interleukin-2 and interferon-alfa-2a for metastatic melanoma. J. Clin. Oncol. 11, 2173-2180.
10. Lee, S.M., Betticher, D.C. & Thatcher, N. (1995) Melanoma: chemotherapy. Brit Med. Bull. 51, 609-630.
11. Lupetti, R., Mortarini, R., Panceri, P., Sensi, M. & Anichini, A. (1996) Interaction with fibronectin regulates cytokine gene expression in human melanoma cells. Int. J. Cancer 66, 110-116.
12. Pantel, K. (1997) Detection of minimal residual disease in patients with epithelial cancer. ABMTR Newslett. 14, 1-5.
13. Rodeck, U. & Herlyn, M. (1991) Growth factors in melanoma. Cancer Metastasis Rev. 10, 89-101.
14. Seftor, E.A., Seftor, R.E.B. & Hendrix, M.J.C. (1990) Selection of invasive and metastatic subpopulation from a heterogenous human melanoma cell line. Bio Techniques 9, 324-331.
15. Singh, R.K., Gutman, M. & Radinsky, R. (1995) Heterogenity of cytokine and growth factor gene expression in human melanoma cells with different metastatic potentials. J. Int. Cyt. Res. 15, 81-87.
16. Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, Ch. & Blair, G.E. (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338, 1227-1229.
17. York, R.M. & Foltz, A.T. (1988) Bleomycin, vincristine, lomustine and DTIC chemotherapy for metastatic melanoma. Cancer 61, 2183-2186.
18. Zatoński, W. & Tyczyński, J. (eds.) (1997) Cancer in Poland in 1994, The M. Sklodowska-Curie Memorial Cancer Center, National Cancer Registry, Warszawa.